Basaglar and Bacterial infection - a phase IV clinical study of FDA data


Bacterial infection is found among people who take Basaglar, especially for people who are male, 60+ old.

The phase IV clinical study analyzes which people take Basaglar and have Bacterial infection. It is created by eHealthMe based on reports of 15,515 people who have side effects when taking Basaglar from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Aug, 09, 2022

15,515 people reported to have side effects when taking Basaglar.
Among them, 10 people (0.06%) have Bacterial infection.

What is Basaglar?

Basaglar has active ingredients of insulin glargine. eHealthMe is studying from 12,313 Basaglar users for its effectiveness, alternative drugs and more.

What is Bacterial infection?

Bacterial infection is found to be associated with 2,426 drugs and 1,591 conditions by eHealthMe.

Number of Basaglar and Bacterial infection reports submitted per year:

Could Basaglar cause Bacterial infection?

Gender of people who have Bacterial infection when taking Basaglar *:

  • female: 40 %
  • male: 60 %

Age of people who have Bacterial infection when taking Basaglar *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 14.29 %
  • 40-49: 14.29 %
  • 50-59: 28.57 %
  • 60+: 42.86 %

Common drugs people take besides Basaglar *:

  1. Humalog: 5 people, 50.00%
  2. Lantus: 3 people, 30.00%
  3. Isentress: 2 people, 20.00%
  4. Pantoprazole: 2 people, 20.00%
  5. Zantac: 2 people, 20.00%
  6. Miralax: 2 people, 20.00%
  7. Lantus Solostar: 2 people, 20.00%
  8. Juluca: 2 people, 20.00%
  9. Zyrtec: 2 people, 20.00%
  10. Potassium: 2 people, 20.00%

Common side effects people have besides Bacterial infection *:

  1. High Blood Pressure: 3 people, 30.00%
  2. Hospitalisation: 3 people, 30.00%
  3. Emotional Distress: 2 people, 20.00%
  4. Thrombocytopenia (decrease of platelets in blood): 2 people, 20.00%
  5. Blood Count Abnormal: 2 people, 20.00%
  6. Erection Problems: 2 people, 20.00%
  7. Multiple Fractures: 2 people, 20.00%
  8. Nausea (feeling of having an urge to vomit): 2 people, 20.00%
  9. Chronic Kidney Disease: 2 people, 20.00%
  10. Acute Kidney Failure: 2 people, 20.00%

Common conditions people have *:

  1. Type 2 Diabetes: 2 people, 20.00%
  2. Hypersensitivity: 2 people, 20.00%
  3. Hiv Infection: 2 people, 20.00%
  4. Gout (uric acid crystals building up in the body): 2 people, 20.00%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 20.00%
  6. High Blood Pressure: 1 person, 10.00%
  7. Hepatocellular Carcinoma (liver cancer): 1 person, 10.00%
  8. Cardiac Disorder: 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Basaglar and have Bacterial infection?

Check whether Bacterial infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Basaglar:

Bacterial infection treatments and more:

COVID vaccines that are related to Bacterial infection:

How severe was Bacterial infection and when was it recovered:

Expand to all the drugs that have ingredients of insulin glargine:

Common drugs associated with Bacterial infection:

All the drugs that are associated with Bacterial infection:

Common conditions associated with Bacterial infection:

All the conditions that are associated with Bacterial infection:

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine (the active ingredients of Basaglar) and Basaglar (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: